Financhill
Back

Biolase Stock Predictions

Biolase Stock Forecast

  • Is Biolase Stock Undervalued?
    The current Biolase [BIOLQ] share price is $0.0050. The Score for BIOLQ is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • BIOLQ is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Biolase Stock Go Up Next Year?

Data Unavailable

Biolase Stock Rating

Data Unavailable

Biolase Stock Price History

Is BIOLQ stock going to rise?

  • The current trend is relatively stagnant and BIOLQ is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
biolase.com

52-Week Data

52-Week High:
1.8800
52-Week Low:
0.0040

Prediction Charts

Market Cap:
183K
Price in USD:
0.0050
Volume:
81.67K
Beta:
1.6221

Technical Analysis

SMA50:
0.0230
SMA100:
0.0449
SMA200:
0.1025
52-Wk Change:
-99.6%

Stock Predictions

  • Is Biolase stock public?
    Yes, Biolase is a publicly traded company.
  • What is the Biolase stock quote today?
    The Biolase stock price is 0.0050 USD today.
  • How to buy Biolase stock online?
    You can buy Biolase shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 0.0070 0.0075 0.0090 0.0070
Nov-5 0.0050 0.0054 0.0075 0.0050
Nov-6 0.0050 0.0056 0.0060 0.0050
Nov-7 0.0060 0.0045 0.0060 0.0045
Nov-8 0.0040 0.0040 0.0060 0.0040
Nov-11 0.0040 0.0040 0.0059 0.0040
Nov-12 0.0040 0.0050 0.0060 0.0040
Nov-13 0.0050 0.0050 0.0067 0.0050
Nov-14 0.0068 0.0069 0.0070 0.0050
Nov-15 0.0069 0.0050 0.0069 0.0050
Nov-18 0.0050 0.0050 0.0064 0.0040
Nov-19 0.0050 0.0050 0.0064 0.0050
Nov-20 0.0050 0.0050 0.0050 0.0040
Nov-21 0.0055 0.0050 0.0059 0.0050

Biolase Earnings

Data Unavailable

Biolase Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.40 per share, and an increase next year of $0.24 per share.

* Biolase stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.